Global Genomics in Cancer Care Market to Reach $62.1 Billion by 2030
The global market for Genomics in Cancer Care estimated at US$13.5 Billion in the year 2022, is projected to reach a revised size of US$62.1 Billion by 2030, growing at a CAGR of 21% over the analysis period 2022-2030. Instruments, one of the segments analyzed in the report, is projected to record 19.3% CAGR and reach US$25 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Consumables segment is readjusted to a revised 23.3% CAGR for the next 8-year period.The U.S. Market is Estimated at $3.7 Billion, While China is Forecast to Grow at 27.3% CAGR
The Genomics in Cancer Care market in the U.S. is estimated at US$3.7 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$15.6 Billion by the year 2030 trailing a CAGR of 27.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.5% and 18.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 16.3% CAGR.Select Competitors (Total 42 Featured) -
- Affymetrix
- Agilent Technologies
- BGI
- Bio-Rad Laboratories
- Cancer Genetics Inc
- GE Healthcare
- Illumina Inc
- Life technologies
- Myriad Genetics
- Pacific Biosciences
- Perkin Elmer
- Qiagen
- Quest Diagnostics
- Roche Diagnostics
- Sigma Aldrich
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Affymetrix
- Agilent Technologies
- BGI
- Bio-Rad Laboratories
- Cancer Genetics Inc
- GE Healthcare
- Illumina Inc
- Life technologies
- Myriad Genetics
- Pacific Biosciences
- Perkin Elmer
- Qiagen
- Quest Diagnostics
- Roche Diagnostics
- Sigma Aldrich
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 93 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 13.5 Billion |
Forecasted Market Value ( USD | $ 62.1 Billion |
Compound Annual Growth Rate | 21.0% |
Regions Covered | Global |